Verified Supplement Data Primary-sourced

EPA vs DHA (2026): Which Omega-3 Do You Actually Need?

By Erin Rose · Updated · Reviewed against primary sources · Methodology · About Us

EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid — the two long-chain omega-3s in fish and algae oil.

Not medical advice — this summarizes published research; talk to a clinician before starting a supplement, especially at high doses. Methodology.

The verdict

Neither wins outright — match it to your goal. EPA has the evidence for mood/depression (as an EPA-forward formula) and is the omega-3 studied in high-risk heart trials. DHA is the structural one — for pregnancy, infant development, and the eyes — and lowers triglycerides slightly more. For general health, a balanced product is plenty. One honest caveat: in already-healthy adults, neither has been shown to sharpen memory or prevent eye disease.

>2:1 EPA:DHA
EPA-forward formulas (≥60% EPA, 1-2 g EPA) are the ones that work for depression
PMID 31480057 / 21939614
DHA > EPA
DHA lowers triglycerides slightly more (and raises HDL & LDL)
PMID 29425187
0 benefit
across 3 large RCTs — omega-3 didn't improve cognition, dry eye, or AMD in healthy adults
PMID 22696350 / 29652551 / 23644932
For most people (general health)
Sports Research Triple Strength Omega-3 (1250mg)
A balanced EPA+DHA product covers general health — no special ratio needed. This one is 950 mg EPA+DHA in a single triglyceride-form softgel, IFOS-certified. For a specific goal (mood, pregnancy, high-dose), see the picks table below.
Check price →

As an Amazon Associate we earn from qualifying purchases. Picks are ranked by EPA+DHA per dose, form, and cost, never commissions.

The short version: both are essential and most products contain both. EPA is a signaling molecule with the best evidence for depression; DHA is a structural building block of the brain and retina and matters most in pregnancy. Bias the ratio to your goal (EPA-forward for mood, DHA-adequate for pregnancy/eyes); for general health, a balanced product is fine. Below, what the actual trials show — including where the popular claims don't hold up.

What Each One Actually Does

DHA builds; EPA signals. DHA is a physical component of cell membranes — it's concentrated in the retina, brain gray matter, and sperm, where it keeps membranes fluid and functional. EPA is barely present in those tissues; instead it competes with the omega-6 arachidonic acid at the enzymes that make inflammatory signals, nudging the balance toward less inflammation. Both are also raw material for specialized pro-resolving mediators (resolvins and protectins) that help actively switch off inflammation (Serhan 2014, PMID: 24899309) — real biochemistry, though that's a mechanism, not proof a supplement treats any specific disease.

One nuance the label won't tell you: your body converts the plant omega-3 (ALA, from flax and chia) into EPA and DHA very inefficiently — a few percent at best — so pre-formed EPA/DHA from fish or algae is the practical way to raise your levels. And while DHA can spare some EPA (taking DHA slows how fast you burn through EPA), a careful isotope study found DHA is not meaningfully converted backward into new EPA (Metherel 2019, PMID: 31204771).

EPA vs DHA: Head to Head

EPA and DHA compared by role and the strength of the evidence
FactorEPADHA
Primary roleSignaling / anti-inflammatory precursorStructural membrane component
Where it concentratesBlood, immune & endothelial cellsBrain gray matter, retina, sperm
Depression / moodStronger — EPA-forward formulas work (PMID 21939614)DHA-major formulas don't (PMID 31383846)
TriglyceridesLowers them; not linked to DHA's HDL/LDL riseLowers them slightly more; raises HDL & LDL (PMID 29425187)
Brain / eyes / pregnancyMinor structural rolePrimary — the structural omega-3 for development
High-risk heart trialPure EPA cut events in one trial (REDUCE-IT)Mixed EPA+DHA was null in broad trials (VITAL, STRENGTH)
Cognition in healthy adultsNo benefit in a Cochrane review (PMID 22696350)

Mood & Depression: EPA's Strongest Case

This is where the ratio genuinely matters. Multiple meta-analyses converge on the same threshold: omega-3 helps depression only when the formula is EPA-dominant. Supplements with at least 60% EPA showed an antidepressant effect; formulas under 60% EPA — including DHA-major ones — did not (Sublette 2011, PMID: 21939614; Liao 2019, PMID: 31383846). An international nutritional-psychiatry practice guideline recommends 1–2 g/day of net EPA, from pure EPA or an EPA:DHA ratio above 2:1 (Guu 2019, PMID: 31480057).

Two honest caveats: this is studied mostly as an add-on to standard treatment, not a replacement, and the effect is modest — EPA is a reasonable adjunct, not a cure. And most standard fish oils are only about 1:1 to 2:1 EPA:DHA, so hitting a true mood dose usually means a dedicated high-EPA concentrate.

Triglycerides & Cholesterol

Both EPA and DHA lower triglycerides, but the one systematic review that compared them head-to-head found DHA lowers triglycerides slightly more than EPA. DHA also raises HDL ("good") cholesterol and tends to raise LDL cholesterol and LDL particle size (larger, more buoyant particles — a mixed signal), whereas EPA — unlike DHA — was not associated with those HDL/LDL changes in the reviewed trials (Innes & Calder 2018, PMID: 29425187). The evidence base is small, so treat the difference as modest. For an actual clinical triglyceride dose, the target is about 4 g/day of combined EPA+DHA under medical supervision — not a casual over-the-counter habit.

Brain, Eyes & Pregnancy: DHA Is Structural — But Read the Fine Print

DHA is unambiguously the structural omega-3 for the developing brain and retina, which is why it's a staple of prenatal nutrition. During pregnancy and infancy, adequate DHA supports brain and eye development (Rogers 2013, PMID: 23266567); international prenatal guidance commonly targets at least 200 mg DHA/day. That developmental case is solid.

Where the marketing outruns the evidence. The leap from "DHA builds the brain and eyes" to "a DHA supplement will sharpen your thinking or protect your eyes" is not supported by the best trials in already-healthy adults:

  • Cognition: a Cochrane review found omega-3 supplements did not improve cognition or prevent decline in cognitively healthy older adults (PMID: 22696350).
  • Dry eye: the large DREAM trial found 3,000 mg/day EPA+DHA was no better than placebo (PMID: 29652551).
  • Macular degeneration: AREDS2 found adding omega-3 did not slow progression to advanced AMD (PMID: 23644932).

So: prioritize DHA in pregnancy and for a genuinely low intake — but don't buy a DHA supplement expecting a memory or eyesight upgrade.

Heart Health: It's About the Patient, Not the Molecule

The heart story is often mis-told as "EPA beats DHA." What the trials actually show is a population story. In high-risk patients already on a statin with elevated triglycerides, prescription pure EPA (icosapent ethyl, 4 g/day) cut cardiovascular events — 17.2% vs 22.0%, about a 25% relative reduction (REDUCE-IT, PMID: 30415628). But in broad, lower-risk populations, mixed EPA+DHA was null (VITAL, PMID: 30415637), and a high-dose EPA+DHA trial in high-risk patients was stopped early for futility (STRENGTH, PMID: 33190147).

One more asterisk: REDUCE-IT used a mineral-oil placebo, and the placebo group's LDL and inflammatory markers rose — so some researchers argue the EPA "benefit" was partly a placebo harm inflating the gap (PMID: 34370544); the investigators dispute that the oil mattered (PMID: 33061866). Net: for healthy people, fish oil is a reasonable way to top up omega-3, not a proven heart-attack preventive — that benefit is specific to high-risk, high-triglyceride patients under a doctor's care.

Which Ratio for Your Goal

How to bias your EPA:DHA ratio by goal (with the honest evidence)
GoalLean towardWhat the evidence says
General healthBalanced (any combined product)No proven "best" ratio — don't overthink it
Depression / low moodEPA-forward (>2:1), 1-2 g EPAMeta-analyses: only ≥60% EPA formulas work; modest, adjunct effect
Pregnancy / infant developmentDHA-adequate (≥200 mg DHA)DHA is structural for fetal brain/eye development
High triglyceridesEither, high dose (~4 g)DHA lowers TG slightly more; medical-supervision dose
High-risk heart (on a statin)Pure EPA (prescription)Only REDUCE-IT (pure EPA) showed benefit; discuss with your doctor
Brain/eyes in healthy adultsSave your moneyRCTs are null — no cognition/dry-eye/AMD benefit

The Label Math (Don't Get Tricked)

Whatever ratio you want, read the actual EPA and DHA numbers — not the "fish oil" total. A typical label:

  • Fish Oil: 1,200 mg — total oil weight, mostly irrelevant.
  • EPA: 360 mg + DHA: 240 mg = 600 mg EPA+DHA — this is what actually counts, and it tells you the ratio (here, 1.5:1).

To reach a 1,000 mg EPA+DHA target with that product you'd need about two softgels. Always add EPA and DHA yourself, and make sure the form is triglyceride, not ethyl ester.

Omega-3 Picks by Goal

EPA+DHA per serving is pulled live from our product data, so it matches our full buying guide. For a true mood dose you'll usually want a dedicated high-EPA concentrate (most standard fish oils aren't EPA-forward enough).

Omega-3 picks by goal (EPA+DHA per serving from live product data)
GoalProductEPA+DHA/ServingWhyBuy
General health Sports Research Triple Strength 950mg Balanced EPA:DHA in one softgel; best value of the triglyceride-form picks Buy
High dose Viva Naturals Triple Strength 2,070mg Most EPA+DHA per serving — for 2,000 mg+ targets Buy
Pregnancy / vegan Nordic Naturals Algae Omega 585mg DHA-forward algal oil; the only pre-formed EPA/DHA without fish Buy

See the full fish-oil comparison for form, certification, and cost per serving across all the products we track.

A Note on Safety

High-dose omega-3 has two real cautions. Above about 3 g/day, fish oil has a mild blood-thinning effect — if you take an anticoagulant or antiplatelet medication, have a bleeding disorder, or have surgery coming up, talk to your doctor first. Separately, high-dose omega-3 (≥3-4 g/day) was linked to a higher rate of atrial fibrillation in the REDUCE-IT and STRENGTH trials (PMID: 30415628, PMID: 33190147), so anyone with a history of AFib or arrhythmia should check with a doctor before high-dose use.

Frequently Asked Questions

What is the difference between EPA and DHA?

DHA is structural — a building block of brain and retinal membranes. EPA is more of a signaling molecule and has the strongest evidence for depression. Most fish oil has both; the ratio varies. Balanced is fine for general health; bias the ratio for a specific goal.

Should I take more EPA or DHA?

By goal: mood → EPA-forward (≥60% EPA, >2:1, 1-2 g EPA; PMID: 21939614, 31383846, 31480057); pregnancy/eyes → DHA-adequate; triglycerides → DHA has a slight edge (PMID: 29425187); general health → balanced, no magic ratio.

Does DHA make you smarter or improve memory?

Not in healthy adults — a Cochrane review found no cognitive benefit or protection from decline (PMID: 22696350). DHA is structurally important for the developing brain (pregnancy/infancy), not a memory booster for grown-ups.

Is EPA or DHA better for lowering triglycerides?

Both work; head-to-head DHA lowers them slightly more, while also raising HDL and LDL; EPA wasn't linked to those cholesterol changes (PMID: 29425187). A clinical dose is ~4 g/day EPA+DHA under medical supervision.

Does fish oil help dry eyes or prevent macular degeneration?

The best trials say no — DREAM found no dry-eye benefit over placebo (PMID: 29652551) and AREDS2 found no slowing of advanced AMD (PMID: 23644932).

Which EPA:DHA ratio is best?

There's no single magic ratio. EPA-forward (>2:1) for mood; DHA-adequate for pregnancy/eyes; pure EPA (prescription) for high-risk heart patients; balanced for everyone else.

Related Guides

Sources

  1. Sublette ME, et al. "Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression." J Clin Psychiatry. 2011;72(12):1577-1584. PMID: 21939614
  2. Liao Y, et al. "Efficacy of omega-3 PUFAs in depression: A meta-analysis." Transl Psychiatry. 2019;9(1):190. PMID: 31383846
  3. Guu TW, et al. "International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder." Psychother Psychosom. 2019;88(5):263-273. PMID: 31480057
  4. Innes JK, Calder PC. "The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review." Int J Mol Sci. 2018;19(2):532. PMID: 29425187
  5. Metherel AH, et al. "Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation." Am J Clin Nutr. 2019;110(4):823-831. PMID: 31204771
  6. Sydenham E, et al. "Omega 3 fatty acid for the prevention of cognitive decline and dementia." Cochrane Database Syst Rev. 2012;(6):CD005379. PMID: 22696350
  7. Asbell PA, et al. "n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease (DREAM)." N Engl J Med. 2018;378(18):1681-1690. PMID: 29652551
  8. Chew EY, et al. "Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration (AREDS2)." JAMA. 2013;309(19):2005-2015. PMID: 23644932
  9. Rogers LK, Valentine CJ, Keim SA. "DHA supplementation: current implications in pregnancy and childhood." Pharmacol Res. 2013;70(1):13-19. PMID: 23266567
  10. Serhan CN. "Pro-resolving lipid mediators are leads for resolution physiology." Nature. 2014;510(7503):92-101. PMID: 24899309
  11. Bhatt DL, et al. "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT)." N Engl J Med. 2019;380(1):11-22. PMID: 30415628
  12. Manson JE, et al. "Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL)." N Engl J Med. 2019;380(1):23-32. PMID: 30415637
  13. Nicholls SJ, et al. "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events (STRENGTH)." JAMA. 2020;324(22):2268-2280. PMID: 33190147
  14. Bostrom JA, Beckman JA, Berger JS. "Summoning STRENGTH to Question the Placebo in REDUCE-IT." Circulation. 2021;144(6):407-409. PMID: 34370544
  15. Olshansky B, et al. "Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies." Eur Heart J Suppl. 2020;22(Suppl J):J34-J48. PMID: 33061866
  16. NIH Office of Dietary Supplements. "Omega-3 Fatty Acids: Fact Sheet for Health Professionals." ods.od.nih.gov